Survival in gastric and esophageal cancers in the Nordic countries through a half century
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F23%3A10471095" target="_blank" >RIV/00216208:11140/23:10471095 - isvavai.cz</a>
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=aOfiOjapRO" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=aOfiOjapRO</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/cam4.5748" target="_blank" >10.1002/cam4.5748</a>
Alternative languages
Result language
angličtina
Original language name
Survival in gastric and esophageal cancers in the Nordic countries through a half century
Original language description
Background: Gastric cancer (GC) and esophageal cancer (EC) are among the most fatal cancers and improving survival in them is a major clinical challenge. Nordic cancer data were recently released up to year 2019. These data are relevant for long- term survival analysis as they originate from high-quality national cancer registries from countries with practically free access to health care, thus documenting "real-world' experience for entire populations.Patients/Methods: Data were obtained for Danish (DK), Finnish (FI), Norwegian (NO), and Swedish (SE) patients from the NORDCAN database from years 1970 through 2019. Relative 1-and 5- year survival were analyzed, and additionally the difference between 1-and 5- year survival was calculated as a measure of trends between years 1 and 5 after diagnosis.Results: Relative 1- year survival for Nordic men and women in GC was 30% in period 1970- 74 and it increased close to 60%. Early 5- year survival ranged be-tween 10 and 15% and the last figures were over 30% for all women and NO men while survival for other men remain below 30%. Survival in EC was below that in GC, and it reached over 50% for 1- year survival only for NO patients; 5- year survival reached over 20% only for NO women. For both cancers, the difference between 1-and 5- year survival increased with time. Survival was worst among old patients.Conclusion: GC and EC survival improved over the 50- year period but the in-crease in 5- year survival was entirely explained by gains in 1- year survival, which improved at an accelerated pace in EC. The likely reasons for improvements are changes in diagnosis, treatment, and care. The challenges are to push survival past year 1 with attention to old patients. These cancers have a potential for pri-mary prevention through the avoidance of risk factors.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30204 - Oncology
Result continuities
Project
—
Continuities
R - Projekt Ramcoveho programu EK
Others
Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Cancer Medicine
ISSN
2045-7634
e-ISSN
—
Volume of the periodical
12
Issue of the periodical within the volume
9
Country of publishing house
GB - UNITED KINGDOM
Number of pages
10
Pages from-to
10212-10221
UT code for WoS article
000940470200001
EID of the result in the Scopus database
2-s2.0-85149906828